Working… Menu
Trial record 9 of 21 for:    "Acinar Cell Carcinoma" | "Immunosuppressive Agents"

Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00397787
Recruitment Status : Completed
First Posted : November 10, 2006
Last Update Posted : June 4, 2013
Information provided by (Responsible Party):
National Cancer Institute (NCI)